" class="no-js "lang="en-US"> 360biolabs - Medtech Alert
Tuesday, March 21, 2023
360biolabs | Pharmtech Focus


About 360biolabs


360biolabs is a contract service organisation providing specialist expertise and laboratory services for the development of new therapeutics, vaccines and diagnostics in a quality-assured environment.

> Diverse range of assays and biomarker endpoints for clinical trials and preclinical studies in many therapeutic areas
> Particular expertise in virology, immunology and analytical chemistry
> World-class facilities with BSL-2, BSL-3 & quarantine laboratories
> Quality management systems (ISO / IEC 17025 & 15189 and OECD Principles of GLP) to ensure that “every sample counts”
> Scalable capabilities from research to late stage clinical trials
> Highly experienced in the design, optimisation and validation of assays with industry standard and regulator compliant reporting
> Proven track record of working with leading pharmaceutical and biotech companies, universities and institutes


Our experienced team is able to conduct a wide array of assays and offers diverse specialist services. Examples include:

• Anti-drug antibodies (ADA)
• T cell and humoral response
• Isolation and cryopreservation (e.g. PBMC, plasma and serum)
• Neutralisation (including PRNT50 and microneutralization)
• Flow cytometry
• Receptor occupancy
• Bioanalytical (ligand and LC/MS based)
• Multiplex bead array (e.g. for cytokine profiling)
• Phagocytic function and oxidative burst
• ELISpot
• Cell migration
• Antiviral activity and mechanism of action (multiple assay types)
• Cytotoxicity
• Qualitative and quantitative culture for multiple virus species
• Qualitative and quantitative PCR and RT-PCR
• Resistance characterisation and resistance monitoring
• Clinical sample logistics and clinical site sample collection kits
• Laboratory manuals
• Biobanking

Related Story

BioAgilytix to Purchase Australia-Based 360biolabs®

August 16 2021

BioAgilytix Labs, LLC (BioAgilytix), a leading global contract research laboratory focused on supporting its pharmaceutical […]